Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: Evidence grom genome-wide analysis

Arthritis and Rheumatism

Volumn 65, Issue 9, 2013, Pages 2457-2468

  Xie, Gang ^a   Roshandel, Delnaz ^a   Sherva, Richard ^b   Monach, Paul A ^b   Lu, Emily Yue ^c   Kung, Tabitha ^a   Carrington, Keisha ^a   Zhang, Steven S ^a   Pulit, Sara L ^d   Ripke, Stephan ^e   Carette, Simon ^a   Dellaripa, Paul F ^d   Edberg, Jeffrey C ^f   Hoffman, Gary S ^g   Khalidi, Nader ^h   Langford, Carol A ^g   Mahr, Alfred D ⁱ   St clair, E William ^j   Seo, Philip ^k   Specks, Ulrich ^l   Spiera, Robert F ^m   Stone, John H ^e   Ytterberg, Steven R ^l   Raychaudhuri, Soumya ^n,r   De Bakker, Paul I W ^d   Farrer, Lindsay A ^b   Amos, Christopher I ^c,o   Merkel, Peter A ^b,p   Siminovitch, Katherine A ^a,q   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j DUKE UNIVERSITY MEDICAL CENTER   (United States)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l MAYO CLINIC   (United States)

^m HOSPITAL FOR SPECIAL SURGERY   (United States)

ⁿ LABORATORY FOR MOLECULAR MEDICINE   (United States)

^o DARTMOUTH MEDICAL SCHOOL   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^r UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; SEMAPHORIN; SEMAPHORIN 6A; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EUROPEAN AMERICAN; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPLICATION STUDY; SEMA6A GENE; SINGLE NUCLEOTIDE POLYMORPHISM; WEGENER GRANULOMATOSIS;

ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HLA-DP BETA-CHAINS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEMAPHORINS; WEGENER GRANULOMATOSIS;

EID: 84883253741     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38036     Document Type: Article

References (51)

1. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA,. The epidemiology of Wegener's granulomatosis: estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996; 39: 87-92.
2. Mahr AD, Neogi T, Merkel PA,. Epidemiology of Wegener's granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 2006; 24: S82-91.
3. Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, et al, on behalf of the European Vasculitis Study Group (EUVAS). Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism Systemic Vasculitis Task Force. Ann Rheum Dis 2008; 67: 1004-10.
4. Csernok E, Lamprecht P, Gross WL,. Diagnostic significance of ANCA in vasculitis. Nat Clin Pract Rheumatol 2006; 2: 174-5.
5. Chen M, Kallenberg CG,. ANCA-associated vasculitides: advances in pathogenesis and treatment. Nat Rev Rheumatol 2010; 6: 653-64.
6. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 2013; 65: 1-11.
7. Muniain MA, Moreno JC, Gonzalez Campora R,. Wegener's granulomatosis in two sisters. Ann Rheum Dis 1986; 45: 417-21.
8. Knudsen BB, Joergensen T, Munch-Jensen B,. Wegener's granulomatosis in a family: a short report. Scand J Rheumatol 1988; 17: 225-7.
9. Hay EM, Beaman M, Ralston AJ, Ackrill P, Bernstein RM, Holt PJ,. Wegener's granulomatosis occurring in siblings. Br J Rheumatol 1991; 30: 144-5.
10. Stoney PJ, Davies W, Ho SF, Paterson IC, Griffith IP,. Wegener's granulomatosis in two siblings: a family study. J Laryngol Otol 1991; 105: 123-4.
11. Rottem M, Cotch MF, Fauci AS, Hoffman GS,. Familial vasculitis: report of 2 families. J Rheumatol 1994; 21: 561-3.
12. Nowack R, Lehmann H, Flores-Suarez LF, Nanhou A, van der Woude FJ,. Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis. Am J Kidney Dis 1999; 34: 364-73.
13. Knight A, Sandin S, Askling J,. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease. Arthritis Rheum 2008; 58: 302-7.
14. Weiner SR, Kwan LW, Paulus HE, Caro XJ, Weisbart RH,. Twins discordant for Wegener's granulomatosis. Clin Exp Rheumatol 1986; 4: 389-90.
15. Abdou NI, Kullman GJ, Hoffman GS, Sharp GC, Specks U, McDonald T, et al. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J Rheumatol 2002; 29: 309-16.
16. Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, et al. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004; 114: 468-77.
17. Borgmann S, Endisch G, Urban S, Sitter T, Fricke H,. A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis. Clin Immunol 2001; 98: 244-8.
18. 1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis. Arthritis Rheum 2010; 62: 3760-7.
19. Giscombe R, Wang X, Huang D, Lefvert AK,. Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis. J Rheumatol 2002; 29: 950-3.
20. Spriewald BM, Witzke O, Wassmuth R, Wenzel RR, Arnold ML, Philipp T, et al. Distinct tumour necrosis factor α, interferon γ, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis. Ann Rheum Dis 2005; 64: 457-61.
21. Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B,. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005; 52: 4039-43.
22. Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007; 39: 721-3.
23. Gencik M, Meller S, Borgmann S, Fricke H,. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 2000; 58: 2473-7.
24. Wieczorek S, Hoffjan S, Chan A, Rey L, Harper L, Fricke H, et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009; 10: 591-5.
25. Wieczorek S, Holle JU, Bremer JP, Wibisono D, Moosig F, Fricke H, et al. Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener's granulomatosis and Churg-Strauss syndrome. Rheumatology (Oxford) 2010; 49: 907-14.
26. Bartfai Z, Gaede KI, Russell KA, Murakozy G, Muller-Quernheim J, Specks U,. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin Immunol 2003; 109: 330-7.
27. Wieczorek S, Holle JU, Muller S, Fricke H, Gross WL, Epplen JT,. A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. J Mol Med 2010; 88: 413-21.
28. Yu X, Wieczorek S, Franke A, Yin H, Pierer M, Sina C, et al. Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. Genes Immun 2009; 10: 601-5.
29. Murakozy G, Gaede KI, Ruprecht B, Gutzeit O, Schurmann M, Schnabel A, et al. Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis. J Mol Med 2001; 79: 665-70.
30. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012; 367: 214-23.
31. Chung SA, Xie G, Roshandel D, Sherva R, Edberg JC, Kravitz M, et al. Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. Arthritis Rheum 2012; 64: 3463-71.
32. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
33. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40: 616-22.
34. The WGET Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 2002; 23: 450 - 68.
35. The WGET Research Group. The Wegener's Granulomatosis Etanercept Trial (WGET): randomized, double-masked, placebo-controlled trial of etanercept for the induction and maintenance of remission. N Engl J Med 2005; 352: 351-61.
36. Green RC, McNagny SE, Jayakumar P, Cupples LA, Benke K, Farrer LA, et al. Statin use and the risk of Alzheimer's disease: the MIRAGE study. Alzheimers Dement 2006; 2: 96-103.
37. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75.
38. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D,. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-9.
39. Howie BN, Donnelly P, Marchini J,. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: e1000529.
40. Mills RE, Walter K, Stewart C, Handsaker RE, Chen K, Alkan C, et al. Mapping copy number variation by population-scale genome sequencing. Nature 2011; 470: 59-65.
41. Brown WM, Pierce J, Hilner JE, Perdue LH, Lohman K, Li L, et al. Overview of the MHC fine mapping data. Diabetes Obes Metab 2009; 11 Suppl 1: 2-7.
42. Holdsworth R, Hurley CK, Marsh SG, Lau M, Noreen HJ, Kempenich JH, et al. The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 2009; 73: 95-170.
43. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, et al, International HIV Controllers Study. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010; 330: 1551-7.
44. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012; 44: 291-6.
45. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C,. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985; 122: 904-14.
46. Szyld P, Jagiello P, Csernok E, Gross WL, Epplen JT,. On the Wegener granulomatosis associated region on chromosome 6p21.3. BMC Med Genet 2006; 7: 21.
47. Heckmann M, Holle JU, Arning L, Knaup S, Hellmich B, Nothnagel M, et al. The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann Rheum Dis 2008; 67: 972-9.
48. Gautier G, de Saint-Vis B, Senechal B, Pin JJ, Bates EE, Caux C, et al. The class 6 semaphorin SEMA6A is induced by interferon-γ and defines an activation status of Langerhans cells observed in pathological situations. Am J Pathol 2006; 168: 453-65.
49. Kumanogoh A, Kikutani H,. Semaphorins and their receptors: novel features of neural guidance molecules. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 611-20.
50. Ji JD, Ivashkiv LB,. Roles of semaphorins in the immune and hematopoietic system. Rheumatol Int 2009; 29: 727-34.
51. Takamatsu H, Okuno T, Kumanogoh A,. Regulation of immune cell responses by semaphorins and their receptors. Cell Mol Immunol 2010; 7: 83-8. and Skin Diseases